Development of semi-solid cosmetic formulations containing coenzyme Q10-loaded nanocapsules

Latin American Journal of Pharmacy

Volumn 28, Issue 6, 2009, Pages 819-826

  Terroso, Thatiana ^a   Külkamp, Irene C ^a   Jornada, Denise S ^a   Pohlmann, Adriana R ^a   Guterres, Sílvia S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Coenzyme Q10; Nanocapsules; Rheological characterization; Semi solid formulations

Indexed keywords

COSMETIC; NANOCAPSULE; UBIDECARENONE;

ARTICLE; DRUG FORMULATION; DRUG STRUCTURE; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 75749129065     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Halliwell, B. (1994) Lancet 344: 721-4.
2. Pompella, A. (1997) Int. J. Vitam. Nutr. Res. 67: 289-97.
3. Sies, H. & W. Stahl (1995) Am. J. Clin. Nutr. 62: 1315S-21S.
4. Machlin, L.J. (1992) Ann. N. . Acad. Sci. 669: 1-6.
5. Sander, C.S., H. Chang, S. Salzmann, C.S. Muller, S. Ekanayake- Mudiyanselage, P. Elsner & J.J. Thiele (2002) J. Invest. Dermatol. 118: 618-25.
6. Halliwell, B. (1999) Free. Radic. Res. 31: 261-72.
7. Gutteridge, J. M. & J. Mitchell (1999) Br. Med. Bull. 55: 49-75.
8. Harman, D. (1956) J. Gerontol. 11: 298-300.
9. Trommer, H. & R.H. Neubert (2005) J. Pharm. Sci. 8: 494-506.
10. Crane, F.L. & J.L. Glenn, (1957) Biochim. Biophys. Acta 24: 100-7.
11. Grossi, G., A.M. Bargossi, P.L. Fiorella, S. Piazzi, M. Battino & G.P. Bianchi (1992) J. Chromatogr. 593: 217-26.
12. Crane, F.L. (1977) Annu. Rev. Biochem. 46: 439-69.
13. Ernster, L. & G. Dallner (1995) Biochim. Biophys. Acta 1271: 195-204.
14. Crane, F.L. & P. Navas (1997) Mol. Aspects Med. 18: S1-6.
15. James, A.M., R.A. Smith & M.P. Murphy (2004) Arch. Biochem. Biophys. 423: 47-56.
16. Turunen, M., J. Olsson & G. Dallner (2004) Biochim. Biophys. Acta 1660: 171-99.
17. Hoppe, U., J. Bergemann, W. Diembeck, J. Ennen, S. Gohla, I. Harris, J. Jacob, J. Kielholz, W. Mei, D. Pollet, D. Schachtschabel, G. Sauermann, V. Schreiner, F. Stab & F. Steckel (1999) Biofactors 9: 371-378.
18. Alonso, M.J.D. (2004) Biomed. Pharmacother. 58: 168-72.
19. Schaffazick, S. R., A.R. Pohlmann, T. Dalla-Costa & S. S Guterres. (2003) Eur. J. Pharm. Biopharm. 56: 501-5.
20. Teeranachaideekul, V., E. B. Souto, V. B. Junyaprasert, & R. H. Muller (2007) Eur. J. Pharm. Biopharm. 67: 141-8.
21. Schaffazick, S.R., S.Guterres, L.L Freitas & A.R. Pohlmann (2003) Quím. Nova 26: 726-37.
22. Schaffazick, S.R., A.R. Pohlmann, C. A. de Cordova, T.B. Creczynski-Pasa, & S.S. Guterres (2005) Int. J. Pharm. 289: 209-13.
23. Guterres, S.S., M.P. Alves & A.R. Pohlmann (2007) Drug Target Insights 2: 147-57.
24. Jenning, V., A. Gysler, M. Schafer-Korting & S.H. Gohla (2000) Eur. J. Pharm. Biopharm. 49: 211-8.
25. Jenning, V., M. Schafer-Korting & S. Gohla (2000) J. Control. Release 66: 115-26.
26. Müller, C.R., S.E. Haas, V.L Bassani, S.S Guterres, H. Fessi, M.R. Peralba & A.R. Pohlmann (2004) Quim. Nova 27: 555.
27. Palumbo, M., A. Russo, V. Cardile, M. Renis, D. Paolino, G. Puglisi & M. Fresta (2002) Pharm. Res. 19: 71-8.
28. Schaffazick, S.R., I.R. Siqueira, A.S. Badejo, D.S. Jornada, A.R. Pohlmann, C.A. Netto & S.S. Guterres (2008) Eur. J. Pharm. Biopharm. 69: 64-71.
29. Rona, C., F. Vailati & E. Berardesca (2004) J. Cosmet. Dermatol. 3: 26-34.
30. Frei, B., M. C. Kim & B. N. Ames (1990) Proc. Natl. Acad. Sc.i U.S.A. 87: 4879-83.
31. Lutka & J. Pawlaczyk (1995) Acta Pol. Pharm. 52: 379-86
32. Takeuchi, H., H. Sasaki, T. Niwa, T. Hino, Y. Kawashima, K. Uesugi & H. Ozawa (1992) Int. J. Pharm. 86: 25-33.
33. Nazzal, S., II. Smalyukh, O.D. Lavrentovich & M.A. Khan (2002) Int. J. Pharm. 235: 247-65.
34. Nehilla, B.J., M. Bergkvist, K.C. Popat & T.A. Desai (2008) Int. J. Pharm. 348: 107-14.
35. Hatanaka, J., Y. Kimura, Z. Lai-Fu, S. Onoue & S. Yamada (2008) Int. J. Pharm. 363: 112-7.
36. Kwon, S.S., Y.S. Nam, J.S. Lee, B.S. Ku, S.H. Han, J.Y. Lee & I.S. Chang (2002) Eng. Asp. 210: 95-104.
37. Coffin M.D. & J.W. Mcginity (1992) Pharm. Res. 9: 200.
38. Woolfson, A.D., R.K. Malcolm, K. Campbell, D.S. Jones, J.A. Russell (2000) J. Control. Release 67: 395-408.
39. Fessi, H., F. Puisieux, J. Ph. Devissaguet, N. Ammoury & S. Benita (1989) Int. J. Pharm. 55: R1-R4.
40. ANVISA, Agência Nacional de Vigilância Sanitária (2003) Resolução RE No 899, de 29 de Maio de 2003. Diário Oficial da República Federativa do Brasil, Brasília DOU de 02/06/2003.
41. Cruz, L., S.R. Schaffazick, T. Dalla Costa, L.U. Soares, G. Mezzalira, N.P. da Silveira, E.E. Schapoval, A.R. Pohlmann, & S.S. Guterres (2006) J. Nanosci. Nanotechnol. 6: 3154-62.
42. Michalowski, C.B., S.S. Guterres & T. Dalla Costa (2004) J. Pharm. Biomed. Anal. 35: 1093-100.
43. Tewa-Tagne, P., S. Briancon & H. Fessi (2006) Int. J. Pharm. 325: 63-74.
44. Franks, F. (1998) Eur. J. Pharm. Biopharm. 45: 221-9.
45. Schmidt C. & R. Bodmeier (1999) J. Control. Release 57: 115-25.
46. Müller C.R., V.L. Bassani, A.R. Pohlmann, C.B. Michalowski, P.R. Petrovick & S.S. Guterres (2000) Drug Dev. Ind. Pharm. 26: 343-7.
47. Alves, P.M., A.R. Pohlmann & S.S. Guterres (2005) Pharmazie 60: 900-4.
48. Lucero M.J., M.J. León, J. Vigo & A.M. Rabasco (1991) Ind. Farm. 6: 62-8.
49. Gungor, S. & N. Bergisadi (2003) Pharmazie 58: 155-6.